Novartis | NOVN

Stock Price
90.17
Daily Change
-0.22%
Yearly
7.45%
Q2 Forecast
87.26
Rating
Sell

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
AbbVie 138.14 0.54 0.39% -3.53%
Alcon AG 71.24 0.32 0.45% 2.80%
Almirall 8.69 0.02 0.17% -14.22%
Amgen 218.76 -2.00 -0.91% -8.85%
Artemis Alpha 315.50 -3.50 -1.10% 0.80%
AstraZeneca 11,712.00 -38.00 -0.32% 18.89%
Bayer 51.15 -0.80 -1.54% -19.52%
Biogen 308.88 3.98 1.31% 52.74%
Bristol-Myers Squibb 64.80 -0.51 -0.78% -13.70%
Fresenius Medical Care 42.34 -0.53 -1.24% -17.01%
Fresenius 25.83 -0.17 -0.65% -13.99%
Genmab 2,676.00 -12.00 -0.45% 29.53%
Gilead Sciences 78.12 -0.28 -0.36% 28.61%
Galapagos 39.95 0.39 0.99% -25.33%
Grifols 11.39 0.04 0.31% -37.57%
GlaxoSmithKline 1,378.00 2.80 0.20% -20.65%
Hikma Pharmaceutical 1,890.50 52.00 2.83% 19.39%
J&J 160.01 -0.25 -0.16% -7.27%
Eli Lilly 446.81 0.38 0.09% 50.44%
Lonza 562.80 -15.20 -2.63% 3.65%
Merck 168.55 -0.65 -0.38% -0.06%
Merck & Co 110.71 0.39 0.35% 26.99%
Novartis 90.17 -0.20 -0.22% 7.45%
Orion 39.96 0.44 1.11% 9.33%
Pfizer 38.97 -0.12 -0.31% -22.01%
Philips 18.24 0.11 0.60% -17.36%
Recordati 44.39 -0.46 -1.03% 19.88%
Regeneron Pharmaceuticals 746.60 -3.60 -0.48% 30.57%
Roche Holding 282.10 -1.85 -0.65% -10.14%
Sanofi 95.40 -0.04 -0.04% -1.52%
UCB 85.66 0 0% 5.29%

Indexes Price Day Year
CH20 11254 -54.48 -0.48% 1.53%

Novartis

Novartis traded at 90.17 this Friday June 9th, decreasing 0.20 or 0.22 percent since the previous trading session. Looking back, over the last four weeks, Novartis lost 1.93 percent. Over the last 12 months, its price rose by 7.45 percent. Looking ahead, we forecast Novartis to be priced at 87.26 by the end of this quarter and at 81.23 in one year, according to Trading Economics global macro models projections and analysts expectations.

Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.